China Injectable Nanomedicines Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Injectable Nanomedicines industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Bausch & Lomb

    • Hoffmann-La Roche

    • Teva Pharmaceutical Industries

    • Janssen Biotech

    • Lupin

    • Merck

    • Celgene Pharmaceutical

    • Pacira Pharmaceuticals

    • Amgen

    By Type:

    • Polymeric Nanoparticles

    • Other

    • Micelles

    • Liposomes

    • Nanocrystals

    By Application:

    • Cancer

    • Other

    • Infection Control

    • Cardiovascular Disease

    • Central Nervous System Disease

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Injectable Nanomedicines Market Overview 2018-2029

    • 1.1 China Injectable Nanomedicines Industry Development Overview

    • 1.2 China Injectable Nanomedicines Industry Development History

    • 1.3 China Injectable Nanomedicines Industry Market Size (2018-2029)

    • 1.4 China Injectable Nanomedicines Market Analysis by Type from Production Side

      • 1.4.1 China Injectable Nanomedicines Production Volume, Production Value and Growth Rate of Polymeric Nanoparticles (2018-2029)

      • 1.4.2 China Injectable Nanomedicines Production Volume, Production Value and Growth Rate of Other (2018-2029)

      • 1.4.3 China Injectable Nanomedicines Production Volume, Production Value and Growth Rate of Micelles (2018-2029)

      • 1.4.4 China Injectable Nanomedicines Production Volume, Production Value and Growth Rate of Liposomes (2018-2029)

      • 1.4.5 China Injectable Nanomedicines Production Volume, Production Value and Growth Rate of Nanocrystals (2018-2029)

    • 1.5 China Injectable Nanomedicines Market Analysis by Application from Consumption End

      • 1.5.1 China Injectable Nanomedicines Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

      • 1.5.2 China Injectable Nanomedicines Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.3 China Injectable Nanomedicines Sales Volume, Sales Value and Growth Rate of Infection Control (2018-2029)

      • 1.5.4 China Injectable Nanomedicines Sales Volume, Sales Value and Growth Rate of Cardiovascular Disease (2018-2029)

      • 1.5.5 China Injectable Nanomedicines Sales Volume, Sales Value and Growth Rate of Central Nervous System Disease (2018-2029)

    • 1.6 China Injectable Nanomedicines Market Analysis by Region

      • 1.6.1 North China Injectable Nanomedicines Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Injectable Nanomedicines Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Injectable Nanomedicines Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Injectable Nanomedicines Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Injectable Nanomedicines Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Injectable Nanomedicines Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Injectable Nanomedicines Market Size and Growth Rate from 2018-2029

    Chapter 2 China Injectable Nanomedicines Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Injectable Nanomedicines Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Injectable Nanomedicines Market Status and Competition Analysis in 2023

      • 2.2.3 China Injectable Nanomedicines Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Injectable Nanomedicines Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Injectable Nanomedicines Industry Development

    Chapter 3 Injectable NanomedicinesIndustry Chain Analysis

    • 3.1 Injectable Nanomedicines Industry Chain

    • 3.2 Injectable Nanomedicines Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Injectable Nanomedicines Market

    • 3.3 Injectable Nanomedicines Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Injectable Nanomedicines Market

    Chapter 4 China Injectable Nanomedicines Market, by Type

    • 4.1 China Injectable Nanomedicines Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Injectable Nanomedicines Total Production Volume and Growth Rate from Production Side

    • 4.5 China Injectable Nanomedicines Production Volume and Growth Rate, by Type

      • 4.5.1 China Injectable Nanomedicines Production Volume and Growth Rate of Polymeric Nanoparticles

      • 4.5.2 China Injectable Nanomedicines Production Volume and Growth Rate of Other

      • 4.5.3 China Injectable Nanomedicines Production Volume and Growth Rate of Micelles

      • 4.5.4 China Injectable Nanomedicines Production Volume and Growth Rate of Liposomes

      • 4.5.5 China Injectable Nanomedicines Production Volume and Growth Rate of Nanocrystals

    Chapter 5 China Injectable Nanomedicines Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Injectable Nanomedicines Total Market Size and Growth Rate from Consumption End

    • 5.5 China Injectable Nanomedicines Market Size and Growth Rate, by Application

      • 5.5.1 China Injectable Nanomedicines Market Size and Growth Rate of Cancer

      • 5.5.2 China Injectable Nanomedicines Market Size and Growth Rate of Other

      • 5.5.3 China Injectable Nanomedicines Market Size and Growth Rate of Infection Control

      • 5.5.4 China Injectable Nanomedicines Market Size and Growth Rate of Cardiovascular Disease

      • 5.5.5 China Injectable Nanomedicines Market Size and Growth Rate of Central Nervous System Disease

    Chapter 6 China Injectable Nanomedicines Market, by Region

    • 6.1 China Injectable Nanomedicines Production Volume and Production Value, by Region

    • 6.2 China Injectable Nanomedicines Sales Volume and Sales Value, by Region

    Chapter 7 North China Injectable Nanomedicines Market Analysis

    • 7.1 North China Injectable Nanomedicines Market, by Type

    • 7.2 North China Injectable Nanomedicines Market, by Application

    Chapter 8 Central China Injectable Nanomedicines Market Analysis

    • 8.1 Central China Injectable Nanomedicines Market, by Type

    • 8.2 Central China Injectable Nanomedicines Market, by Application

    Chapter 9 South China Injectable Nanomedicines Market Analysis

    • 9.1 South China Injectable Nanomedicines Market, by Type

    • 9.2 South China Injectable Nanomedicines Market, by Application

    Chapter 10 East China Injectable Nanomedicines Market Analysis

    • 10.1 East China Injectable Nanomedicines Market, by Type

    • 10.2 East China Injectable Nanomedicines Market, by Application

    Chapter 11 Northeast China Injectable Nanomedicines Market Analysis

    • 11.1 Northeast China Injectable Nanomedicines Market, by Type

    • 11.2 Northeast China Injectable Nanomedicines Market, by Application

    Chapter 12 Southwest China Injectable Nanomedicines Market Analysis

    • 12.1 Southwest China Injectable Nanomedicines Market, by Type

    • 12.2 Southwest China Injectable Nanomedicines Market, by Application

    Chapter 13 Northwest China Injectable Nanomedicines Market Analysis

    • 13.1 Northwest China Injectable Nanomedicines Market, by Type

    • 13.2 Northwest China Injectable Nanomedicines Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Bausch & Lomb

        • 14.1.1 Bausch & Lomb Company Profile

        • 14.1.2 Bausch & Lomb Injectable Nanomedicines Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Hoffmann-La Roche

        • 14.2.1 Hoffmann-La Roche Company Profile

        • 14.2.2 Hoffmann-La Roche Injectable Nanomedicines Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Teva Pharmaceutical Industries

        • 14.3.1 Teva Pharmaceutical Industries Company Profile

        • 14.3.2 Teva Pharmaceutical Industries Injectable Nanomedicines Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Janssen Biotech

        • 14.4.1 Janssen Biotech Company Profile

        • 14.4.2 Janssen Biotech Injectable Nanomedicines Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Lupin

        • 14.5.1 Lupin Company Profile

        • 14.5.2 Lupin Injectable Nanomedicines Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Merck

        • 14.6.1 Merck Company Profile

        • 14.6.2 Merck Injectable Nanomedicines Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Celgene Pharmaceutical

        • 14.7.1 Celgene Pharmaceutical Company Profile

        • 14.7.2 Celgene Pharmaceutical Injectable Nanomedicines Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Pacira Pharmaceuticals

        • 14.8.1 Pacira Pharmaceuticals Company Profile

        • 14.8.2 Pacira Pharmaceuticals Injectable Nanomedicines Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Amgen

        • 14.9.1 Amgen Company Profile

        • 14.9.2 Amgen Injectable Nanomedicines Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Injectable Nanomedicines Industry Research Conclusions

    • 15.2 Injectable Nanomedicines Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Injectable Nanomedicines Industry Market Size (2018-2029)

    • Figure China Injectable Nanomedicines Production Volume, Production Value and Growth Rate of Polymeric Nanoparticles (2018-2029)

    • Figure China Injectable Nanomedicines Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • Figure China Injectable Nanomedicines Production Volume, Production Value and Growth Rate of Micelles (2018-2029)

    • Figure China Injectable Nanomedicines Production Volume, Production Value and Growth Rate of Liposomes (2018-2029)

    • Figure China Injectable Nanomedicines Production Volume, Production Value and Growth Rate of Nanocrystals (2018-2029)

    • Figure China Injectable Nanomedicines Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

    • Figure China Injectable Nanomedicines Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China Injectable Nanomedicines Sales Volume, Sales Value and Growth Rate of Infection Control (2018-2029)

    • Figure China Injectable Nanomedicines Sales Volume, Sales Value and Growth Rate of Cardiovascular Disease (2018-2029)

    • Figure China Injectable Nanomedicines Sales Volume, Sales Value and Growth Rate of Central Nervous System Disease (2018-2029)

    • Figure North China Injectable Nanomedicines Market Size and Growth Rate from 2018-2029

    • Figure Central China Injectable Nanomedicines Market Size and Growth Rate from 2018-2029

    • Figure South China Injectable Nanomedicines Market Size and Growth Rate from 2018-2029

    • Figure East China Injectable Nanomedicines Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Injectable Nanomedicines Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Injectable Nanomedicines Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Injectable Nanomedicines Market Size and Growth Rate from 2018-2029

    • Figure Injectable Nanomedicines Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Injectable Nanomedicines Market Share by Type in 2018

    • Figure China Injectable Nanomedicines Market Share by Type in 2023

    • Figure China Injectable Nanomedicines Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Injectable Nanomedicines Production Volume and Growth Rate of Polymeric Nanoparticles (2018-2023)

    • Figure China Injectable Nanomedicines Production Volume and Growth Rate of Other (2018-2023)

    • Figure China Injectable Nanomedicines Production Volume and Growth Rate of Micelles (2018-2023)

    • Figure China Injectable Nanomedicines Production Volume and Growth Rate of Liposomes (2018-2023)

    • Figure China Injectable Nanomedicines Production Volume and Growth Rate of Nanocrystals (2018-2023)

    • Figure China Injectable Nanomedicines Market Share by Application in 2018

    • Figure China Injectable Nanomedicines Market Share by Application in 2023

    • Figure China Injectable Nanomedicines Total Market Size and Growth Rate from Consumption End

    • Figure China Injectable Nanomedicines Market Size and Growth Rate of Cancer (2018-2023)

    • Figure China Injectable Nanomedicines Market Size and Growth Rate of Other (2018-2023)

    • Figure China Injectable Nanomedicines Market Size and Growth Rate of Infection Control (2018-2023)

    • Figure China Injectable Nanomedicines Market Size and Growth Rate of Cardiovascular Disease (2018-2023)

    • Figure China Injectable Nanomedicines Market Size and Growth Rate of Central Nervous System Disease (2018-2023)

    • Table China Injectable Nanomedicines Production Volume by Region (2018-2023)

    • Table China Injectable Nanomedicines Production Volume Share by Region (2018-2023)

    • Figure China Injectable Nanomedicines Production Volume Share by Region (2018-2023)

    • Table China Injectable Nanomedicines Production Value by Region (2018-2023)

    • Table China Injectable Nanomedicines Production Value Share by Region (2018-2023)

    • Figure China Injectable Nanomedicines Production Value Share by Region (2018-2023)

    • Table China Injectable Nanomedicines Sales Volume by Region (2018-2023)

    • Table China Injectable Nanomedicines Sales Volume Share by Region (2018-2023)

    • Figure China Injectable Nanomedicines Sales Volume Share by Region (2018-2023)

    • Table China Injectable Nanomedicines Sales Value by Region (2018-2023)

    • Table China Injectable Nanomedicines Sales Value Share by Region (2018-2023)

    • Figure China Injectable Nanomedicines Sales Value Share by Region (2018-2023)

    • Table North China Injectable Nanomedicines Production Volume by Type (2018-2023)

    • Table North China Injectable Nanomedicines Production Volume Share by Type (2018-2023)

    • Figure North China Injectable Nanomedicines Production Volume Share by Type (2018-2023)

    • Table North China Injectable Nanomedicines Sales Volume by Application (2018-2023)

    • Table North China Injectable Nanomedicines Sales Volume Share by Application (2018-2023)

    • Figure North China Injectable Nanomedicines Sales Volume Share by Application (2018-2023)

    • Table Central China Injectable Nanomedicines Production Volume by Type (2018-2023)

    • Table Central China Injectable Nanomedicines Production Volume Share by Type (2018-2023)

    • Figure Central China Injectable Nanomedicines Production Volume Share by Type (2018-2023)

    • Table Central China Injectable Nanomedicines Sales Volume by Application (2018-2023)

    • Table Central China Injectable Nanomedicines Sales Volume Share by Application (2018-2023)

    • Figure Central China Injectable Nanomedicines Sales Volume Share by Application (2018-2023)

    • Table South China Injectable Nanomedicines Production Volume by Type (2018-2023)

    • Table South China Injectable Nanomedicines Production Volume Share by Type (2018-2023)

    • Figure South China Injectable Nanomedicines Production Volume Share by Type (2018-2023)

    • Table South China Injectable Nanomedicines Sales Volume by Application (2018-2023)

    • Table South China Injectable Nanomedicines Sales Volume Share by Application (2018-2023)

    • Figure South China Injectable Nanomedicines Sales Volume Share by Application (2018-2023)

    • Table East China Injectable Nanomedicines Production Volume by Type (2018-2023)

    • Table East China Injectable Nanomedicines Production Volume Share by Type (2018-2023)

    • Figure East China Injectable Nanomedicines Production Volume Share by Type (2018-2023)

    • Table East China Injectable Nanomedicines Sales Volume by Application (2018-2023)

    • Table East China Injectable Nanomedicines Sales Volume Share by Application (2018-2023)

    • Figure East China Injectable Nanomedicines Sales Volume Share by Application (2018-2023)

    • Table Northeast China Injectable Nanomedicines Production Volume by Type (2018-2023)

    • Table Northeast China Injectable Nanomedicines Production Volume Share by Type (2018-2023)

    • Figure Northeast China Injectable Nanomedicines Production Volume Share by Type (2018-2023)

    • Table Northeast China Injectable Nanomedicines Sales Volume by Application (2018-2023)

    • Table Northeast China Injectable Nanomedicines Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Injectable Nanomedicines Sales Volume Share by Application (2018-2023)

    • Table Southwest China Injectable Nanomedicines Production Volume by Type (2018-2023)

    • Table Southwest China Injectable Nanomedicines Production Volume Share by Type (2018-2023)

    • Figure Southwest China Injectable Nanomedicines Production Volume Share by Type (2018-2023)

    • Table Southwest China Injectable Nanomedicines Sales Volume by Application (2018-2023)

    • Table Southwest China Injectable Nanomedicines Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Injectable Nanomedicines Sales Volume Share by Application (2018-2023)

    • Table Northwest China Injectable Nanomedicines Production Volume by Type (2018-2023)

    • Table Northwest China Injectable Nanomedicines Production Volume Share by Type (2018-2023)

    • Figure Northwest China Injectable Nanomedicines Production Volume Share by Type (2018-2023)

    • Table Northwest China Injectable Nanomedicines Sales Volume by Application (2018-2023)

    • Table Northwest China Injectable Nanomedicines Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Injectable Nanomedicines Sales Volume Share by Application (2018-2023)

    • Table Bausch & Lomb Company Profile

    • Table Bausch & Lomb Injectable Nanomedicines Revenue, Price and Gross (2018-2023)

    • Table Hoffmann-La Roche Company Profile

    • Table Hoffmann-La Roche Injectable Nanomedicines Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Industries Company Profile

    • Table Teva Pharmaceutical Industries Injectable Nanomedicines Revenue, Price and Gross (2018-2023)

    • Table Janssen Biotech Company Profile

    • Table Janssen Biotech Injectable Nanomedicines Revenue, Price and Gross (2018-2023)

    • Table Lupin Company Profile

    • Table Lupin Injectable Nanomedicines Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Injectable Nanomedicines Revenue, Price and Gross (2018-2023)

    • Table Celgene Pharmaceutical Company Profile

    • Table Celgene Pharmaceutical Injectable Nanomedicines Revenue, Price and Gross (2018-2023)

    • Table Pacira Pharmaceuticals Company Profile

    • Table Pacira Pharmaceuticals Injectable Nanomedicines Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Injectable Nanomedicines Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.